Clinical Trials Directory

Trials / Sponsors / Vascular Biogenics Ltd. operating as VBL Therapeutics

Vascular Biogenics Ltd. operating as VBL Therapeutics

Industry · 11 registered clinical trials.

StatusTrialPhaseStarted
CompletedA Study to Evaluate the Efficacy and Safety of VB-201 in Patients With COVID-19
Severe COVID-19
Phase 22021-01-26
CompletedA Study of VB-111 With Paclitaxel vs Paclitaxel for Treatment of Recurrent Platinum-Resistant Ovarian Cancer (
Recurrent Platinum Resistant Ovarian Cancer
Phase 32017-12-19
CompletedA Phase 3, Pivotal Trial of VB-111 Plus Bevacizumab vs. Bevacizumab in Patients With Recurrent Glioblastoma (G
Glioblastoma
Phase 32015-08-01
CompletedA Study to Evaluate the Efficacy and Safety of VB-201 in Patients With Ulcerative Colitis
Ulcerative Colitis
Phase 22013-01-01
CompletedA Phase I/II Trial of VB-111 and Paclitaxel for Recurrent Platinum-Resistant Müllerian Cancer
Platinum Resistant Ovarian Cancer
Phase 1 / Phase 22012-11-01
CompletedA Study to Evaluate the Efficacy and Safety of VB-201 in Patients With Psoriasis
Psoriasis
Phase 22012-11-01
CompletedSafety and Efficacy of VB-111 in Subjects With Advanced Differentiated Thyroid Cancer
Differential Thyroid Cancer
Phase 22010-12-01
CompletedSingle-Arm Open-Label Multicenter Study of VB-111 in Patients With Recurrent Glioblastoma Multiforme
Glioblastoma Multiforme
Phase 1 / Phase 22010-12-01
CompletedStudy to Assess the Safety and Efficacy of Multiple Doses of VB-201 on Biomarkers
Biomarker
Phase 22010-10-01
CompletedStudy to Assess VB-201 in Patients With Psoriasis
Active Plaque Psoriasis
Phase 22009-12-01
UnknownA Phase I Study to Assess the Safety and Distribution of VB-111 in Patients With Advanced Metastatic Cancer
Advanced and/or Metastatic Solid Organ Cancer
Phase 12007-11-01